Clinical Trial

REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 20, 2025 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
This survey targets controlled ovarian stimulation with this drug for the development of multiple oocytes in women undergoing assisted reproduction (ART) such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-06.
Trial Details
NCT Number NCT06545877
Lead Sponsor Ferring Pharmaceuticals
Conditions Infertility
Enrollment 500 participants
Start Date 2022-09-16
Primary Completion 2026-02-28 (estimated)
Study Completion 2029-06-22 (estimated)
Updated on ClinicalTrials.gov 2025-08-20